Business Wire - September 09, 2009
Dr. Hamburg explained, "In the past, oral cancers were almost always associated with smoking and alcohol abuse but now oncologists have observed that as many as one third to one half of cases are caused by HPV, which is found within the tumor tissue." Normally, the virus is carried in the genital area of an average of about 27 percent of young American women and causes no symptoms, lasts eight to 24 months and then disappears. It is estimated that sooner or later, more than 80% of sexually active women will acquire genital HPV but 90% of these silent infections clear spontaneously. In some individuals it persists and becomes chronic and this group, with HPV, is at greater risk for viral-induced malignancy. In addition, the prevalence of HPV infection in men is about the same.
Education of the public about how this sexually transmitted virus causes throat and genital cancer is essential. A vaccine that significantly reduces the probability of infection is now available, although it is only approved for girls and young women for the prevention of cancer of the cervix. However, according to Dr, Hamburg, there is much pressure at present to expand the indication for vaccination and to include young men as well.
Tower Cancer Research Foundation is a non-profit 501 C(3) organization founded in 1996. The Foundation is dedicated to finding more effective treatments to prevent, treat and, to one day, cure cancer. The Foundation conducts leading-edge clinical trials and develops treatment options for patients suffering from cancer and blood disorders. The Foundation also maintains the Ronnie Lippin Cancer Information and Resource Line (RLCIRL). The RLCIRL is dedicated to helping cancer patients and their families in Los Angeles County cope with complexities and challenges of a cancer diagnosis by providing access to current cancer-related information and resources. RLCIRL can be contacted at either www.lacancerinfo.org or by calling 877-752-2120.
Contacts
The Lippin Group/L.A.
Pam Golum, 323-965-1990
pgolum@lippingroup.com
or
The Lippin Group/N.Y.
Matt Biscuiti, 212-986-7080
matt@lippingroup.com
090909
BW090912
Copyright © 2009 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .